PASURTA®
Solution for injection in a pre-filled syringe
registration number
54/7.3/0587, 54/7.3/0588
What PASURTA® contains
Erenumab 70 mg in 1.0 mL
Erenumab 140 mg in 1.0 mL.
other ingredients
70 mg per mL pre-filled syringe
• Sucrose: 73 mg/7.3 % (w/v); NF, Ph. Eur., JP
• Glacial acetic acid: 1.5 mg/25 mM; USP, Ph. Eur., JP
• Polysorbate 80: 0.10 mg/0.010 % (w/v); NF, Ph. Eur., JP
• Water for injection
• Sodium hydroxide to pH of 5.2; NF, Ph. Eur., JP
140 mg per mL pre-filled syringe
• Sucrose: 65 mg/6.5 % (w/v); NF, Ph. Eur., JP
• Glacial acetic acid: 2.0 mg/34 mM; USP, Ph. Eur., JP
• Polysorbate 80: 0.10 mg/0.010 % (w/v); NF, Ph. Eur., JP
• Water for injection
• Sodium hydroxide to pH of 5.2; NF, Ph. Eur., JP.
Therapeutic classification
N02CD01.